BeOne Medicines Ltd.: director Wang Xiaodong sold 31,027 shares

What happened

• Wang Xiaodong, director, chair and member of the scientific advisory board, exercised options or converted derivatives to acquire 31,027 shares at $36.90 per share for $1,144,896 and sold 31,027 shares in open-market/private transactions on Oct 13, 2026 for total proceeds of $10,890,074. The filing also reports the disposition of 403,351 shares in a derivative transaction at $0.00.

Key details

• Transaction date: Oct 13, 2026.
• Exercise/acquisition: 31,027 shares at $36.90 per share, total $1,144,896 (code M).
• Sales: five open-market/private sale entries totaling 31,027 shares with proceeds of $2,505,306; $3,631,262; $1,996,280; $2,312,148; and $445,078 (total $10,890,074) (code S). Reported sale prices are weighted averages with ranges per footnotes: $348.98–$349.97, $349.98–$350.97, $350.98–$351.97, $351.99–$352.95, and $353.01–$353.325 (see footnotes F6–F10).
• Derivative disposition: 403,351 shares at $0.00 (code M; derivative).
• Footnotes of note: certain securities are held by family trust, by Wang Investment LLC, and by the reporting person's spouse (F1–F3); each American depositary share represents 13 ordinary shares (F4); one sale was effected pursuant to a Rule 10b5-1 trading plan adopted Jun 9, 2026 (F5); option/derivative details and vesting are described in F11 and F12.
• Shares owned after the reported transactions: not specified in the filing.
• Filing date: Oct 15, 2026 (reports transactions on Oct 13, 2026).

Why it may matter

• The filing shows an exercise/conversion of securities and contemporaneous sales of the same number of shares on the same date, which indicates the exercised shares were sold the same day (cashless exercise pattern reflected in the filing).
• Some sales were made under a Rule 10b5-1 trading plan and several holdings are reported as held by trusts or related entities for which the reporting person disclaims beneficial ownership.
• A filing does not show why the insider traded or why the company acted.